Compare AVO & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | DRTS |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2020 | 2021 |
| Metric | AVO | DRTS |
|---|---|---|
| Price | $13.13 | $14.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $17.00 | $8.67 |
| AVG Volume (30 Days) | ★ 656.0K | 496.4K |
| Earning Date | 06-04-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,391,200,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.06 | $699.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.68 | N/A |
| 52 Week Low | $10.07 | $3.18 |
| 52 Week High | $15.53 | $15.02 |
| Indicator | AVO | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.40 | 64.85 |
| Support Level | $13.03 | $6.47 |
| Resistance Level | $14.11 | N/A |
| Average True Range (ATR) | 0.42 | 0.64 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 73.79 | 90.11 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.